ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 2:00pm

Brian Anderson
VP & Assistant General Counsel, IP Litigation
Allergan

Stephanie L. Donahue
Senior Director, Patent Litigation
Sanofi (Bridgewater, NJ)

Hassen A. Sayeed M.D.
Partner
O’Melveny & Myers LLP (New York, NY)

Lisa Jakob
Managing Counsel, Trademark Group
Merck (Rahway, NJ)

Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)

Josephine Liu, Ph.D., J.D.
Head, US IP Litigation
Sandoz Inc. (Princeton, NJ)

John Molenda
Partner
Steptoe & Johnson LLP (New York, NY)

Rekha Hanu, Ph.D, J.D
Executive Director, Chief IP Counsel
Akorn Pharmaceuticals (Lake Forest, IL)

Brian Hirsch
Vice President Global IP and Legal Head North America
Glenmark Pharmaceuticals (Mahwah, NJ)

Jennifer Grant Moitoso
VP, IP
Shire

Track Moderator

Pearl T.L. Siew
Senior Vice President and Head, Intellectual Property
Eagle Pharmaceuticals, Inc.

Esteemed members of ACI’s Hatch-Waxman Series Advisory Board will lead this new breakout track. Limited to 20 attendees* per session, these unique, interactive discussion groups will provide exclusive, and intimate networking and benchmarking opportunities that will shed light on the expectations of in-house counsel from their law firm partners. It is also a vehicle for other in-house counsel to benchmark their current “3C’s” strategies with those of the Board. *To ensure a fair balance of brand name and generic participation, all interested parties will be prequalified before registering. Please click here to register for the tracks .  

2:00 Cost

Monitoring Legal Spend and Balancing the Budget

  • Establishing best practices for cost reduction to enhance predictability for cash flow purposes
  • Identifying processes to assist with budgeting, fee arrangements and billing
  • Examining the value of licensing deals and structures
 

2:45 Competency

Finding the Right Talent with Time-Proven Strategies

  • Considerations in selecting outside counsel
  • Evaluating the appropriateness of work product
  • Reconciling firm capabilities versus individual attorney reputation and ability
 

3:30 Communication

Communicating Value and Collaboration Between Corporate Legal and Outside Counsel

  • Establishing the desired level of commitment, availability and responsiveness early-on in the relationship
  • Succinctly focusing on shared, pragmatic business goals
  • Determining preferences for formality of correspondence and practical versus academic guidance